Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

ALS Crowd Radio

ALS Crowd Radio

×  

Follow This Show

Stay in the know about new episodes and updates.
A show connecting ALS patients with top researchers to educate and empower patients and to narrow the gap between the research and patient communities.

On-Demand Episodes

Dr. Nath is an expert in viruses and retroviruses. He speaks about studying human endogenous retrovirus-K (HERV-K) in the context of ALS, and why it could be important. HERV-K is normally dormant, but Dr. Nath's study found that... more

S2:E5 ALSA President and CEO Barbara Newhouse and Chief Scientist Dr. Lucie Bruijn will speak live from Washington DC at the National ALS Advocacy Day and Public Policy Conference. They will share the advocacy work on Capitol Hill that... more

S2:E4 Dr. Richard Bedlack, MD will describe the ALS Reversals program in detail. Once it starts, ALS almost always continues to progress, disable and shorten lives. Very rarely, a patient with a confirmed diagnosis of ALS gets better on... more

S2:E3 Dr. Paul Alan Cox, Ph.D., Director of the Institute for Ethnomedicine, will speak about his research in finding and fighting the environmental causes of ALS. Dietary exposure to an environmental toxin called BMAA may trigger ALS... more

S2:E2 Dr. Joseph Beckman, Ph.D. will speak about his research findings that have essentially stopped the progressions of ALS for nearly two years in one type of mouse model used to study the disease. This has allowed the mice to... more

Dr. Merit Cudkowicz will kick off ALS Crowd Radio Season 2 with an overview of the state of ALS research and treatment today. As director of MDA ALS Clinic at Massachusetts General Hospital and Professor of Neurology at Harvard Medical... more

Borrowing from one cancer treatment to treat another is common, but the insights learned from a cancer treatment class of drugs could be applied to neurological disorders like ALS. Dr. Alfred Goldberg, PhD of Harvard Medical School has... more

ALS Crowd Radio: Dr. Jonathan Katz on the "Right to Try"

How do we, as the ALS patients, assess is the validity of the alternative or off-label treatments we hear about through friends and family or to the media? ALS expert Dr. Richard Bedlack of Duke University will discuss his research... more

Join us for our interview with Dr. Eva Feldman of the University of Michigan. Topics will include Dr. Feldman expertise in ALS stem cell research.

Comments

 comments